Please enable JavaScript to continue using this application.

Compare $CAMP vs $PYXS | Chartloom

Compare

$CAMP vs $PYXS

CAMP4 Therapeutics Corp · Pyxis Oncology Inc

CAMP

CAMP4 Therapeutics Corp

PYXS

Pyxis Oncology Inc

Compare $CAMP vs $PYXS

Comparing CAMP4 Therapeutics Corp and Pyxis Oncology Inc

CAMPCAMP4 Therapeutics Corp

PYXSPyxis Oncology Inc

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

PYXSPyxis Oncology Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-14.2%

YTD performance

76.5%

52W performance

-30.2%

FCF yield

-40.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAMP

PYXS

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

PYXS

Pyxis Oncology Inc

Market Cap

CAMP$196M

PYXS$168M

Enterprise Value

CAMP$109M

PYXS$150M

Price

CAMP$3.77

PYXS$2.03

P/E Ratio

CAMPN/A

PYXSN/A

P/S Ratio

CAMP46.44x

PYXS15.26x

EV/Sales

CAMP25.94x

PYXS13.55x

EV/EBITDA

CAMP0.00x

PYXS0.00x

P/B Ratio

CAMP8.12x

PYXS15.60x

P/FCF Ratio

CAMPN/A

PYXSN/A

EV/FCF

CAMP-3.81x

PYXS-2.20x

PEG Ratio

CAMPN/A

PYXSN/A

Forward P/E (NTM)

CAMPN/A

PYXSN/A

Forward P/S (NTM)

CAMP19.59x

PYXSN/A

Revenue (TTM)

CAMP$4M

PYXS$11M

Revenue Growth (YoY)

CAMP40.3%

PYXS-14.2%

Forward Rev Growth

CAMP-10.8%

PYXS14187.3%

Gross Margin (TTM)

CAMP35.8%

PYXS78.4%

Operating Margin (TTM)

CAMP0.0%

PYXS0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

PYXS-580.0%

Net Margin (TTM)

CAMP-2543.7%

PYXS-593.0%

FCF Margin (TTM)

CAMP-681.2%

PYXS-615.3%

Net Income (TTM)

CAMP$-107M

PYXS$-65M

FCF (TTM)

CAMP$-29M

PYXS$-68M

EPS (TTM)

CAMP-$1.85

PYXS-$1.03

ROE (TTM)

CAMP-19474.0%

PYXS-10177.0%

ROA (TTM)

CAMP-10642.0%

PYXS-6981.0%

ROIC (TTM)

CAMP-19457.0%

PYXS-10171.0%

Cash

CAMP$86M

PYXS$19M

Debt

CAMP$0

PYXS$0

Net Cash/Debt

CAMP$86M

PYXS$19M

Current Ratio (TTM)

CAMP4.70x

PYXS1.34x

Quick Ratio (TTM)

CAMP4.69x

PYXS1.25x

Debt/Equity (TTM)

CAMP0.00x

PYXS0.00x

Debt/Assets (TTM)

CAMP0.0%

PYXS0.0%

Interest Coverage (TTM)

CAMPN/A

PYXSN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

PYXS0.00x

Beta

CAMP-24.51

PYXS1.37

52W Performance

CAMP6.5%

PYXS-30.2%

YTD Performance

CAMP-37.2%

PYXS76.5%

% from 52W High

CAMP-51.4%

PYXS-63.4%

% from 52W Low

CAMP31.8%

PYXS97.1%

Asset Turnover (TTM)

CAMP0.79x

PYXS0.00x

FCF Yield (TTM)

CAMP-14.7%

PYXS-40.3%

Earnings Yield (TTM)

CAMP-54.8%

PYXS-38.9%

Dividend Yield (TTM)

CAMPN/A

PYXSN/A

Rule of 40

CAMP-640.9

PYXS-629.5

EV/GP/RG

CAMP0.53

PYXS0.00

Ticker research

View CAMP research View PYXS research

Metric	CAMP CAMP4 Therapeutics Corp	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$196M	$168M
Enterprise Value	$109M	$150M
Price	$3.77	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	15.26x
EV/Sales	25.94x	13.55x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$11M
Revenue Growth (YoY)	40.3%	-14.2%
Forward Rev Growth	-10.8%	14187.3%
Profitability
Gross Margin (TTM)	35.8%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-580.0%
Net Margin (TTM)	-2543.7%	-593.0%
FCF Margin (TTM)	-681.2%	-615.3%
Net Income (TTM)	$-107M	$-65M
FCF (TTM)	$-29M	$-68M
EPS (TTM)	-$1.85	-$1.03
ROE (TTM)	-19474.0%	-10177.0%
ROA (TTM)	-10642.0%	-6981.0%
ROIC (TTM)	-19457.0%	-10171.0%
Financial Health
Cash	$86M	$19M
Debt	$0	$0
Net Cash/Debt	$86M	$19M
Current Ratio (TTM)	4.70x	1.34x
Quick Ratio (TTM)	4.69x	1.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.37
52W Performance	6.5%	-30.2%
YTD Performance	-37.2%	76.5%
% from 52W High	-51.4%	-63.4%
% from 52W Low	31.8%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-40.3%
Earnings Yield (TTM)	-54.8%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-629.5
EV/GP/RG	0.53	0.00
Ticker research	View CAMP research	View PYXS research

Valuation

P/S Ratio

PYXS

15.26x

CAMP

46.44x

EV/FCF

CAMP

-3.81x

PYXS

-2.20x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

PYXS

-14.2%

Forward Revenue Growth

PYXS

14187.3%

CAMP

-10.8%

Profitability & performance

Gross Margin

PYXS

78.4%

CAMP

35.8%

ROE

PYXS

-10177.0%

CAMP

-19474.0%

FCF Yield %

CAMP

-14.7%

PYXS

-40.3%

52-Week Performance

CAMP

6.5%

PYXS

-30.2%

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

PYXS

Pyxis Oncology Inc

Market Cap

CAMP$196M

PYXS$168M

Enterprise Value

CAMP$109M

PYXS$150M

Price

CAMP$3.77

PYXS$2.03

P/E Ratio

CAMPN/A

PYXSN/A

P/S Ratio

CAMP46.44x

PYXS15.26x

EV/Sales

CAMP25.94x

PYXS13.55x

EV/EBITDA

CAMP0.00x

PYXS0.00x

P/B Ratio

CAMP8.12x

PYXS15.60x

P/FCF Ratio

CAMPN/A

PYXSN/A

EV/FCF

CAMP-3.81x

PYXS-2.20x

PEG Ratio

CAMPN/A

PYXSN/A

Forward P/E (NTM)

CAMPN/A

PYXSN/A

Forward P/S (NTM)

CAMP19.59x

PYXSN/A

Revenue (TTM)

CAMP$4M

PYXS$11M

Revenue Growth (YoY)

CAMP40.3%

PYXS-14.2%

Forward Rev Growth

CAMP-10.8%

PYXS14187.3%

Gross Margin (TTM)

CAMP35.8%

PYXS78.4%

Operating Margin (TTM)

CAMP0.0%

PYXS0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

PYXS-580.0%

Net Margin (TTM)

CAMP-2543.7%

PYXS-593.0%

FCF Margin (TTM)

CAMP-681.2%

PYXS-615.3%

Net Income (TTM)

CAMP$-107M

PYXS$-65M

FCF (TTM)

CAMP$-29M

PYXS$-68M

EPS (TTM)

CAMP-$1.85

PYXS-$1.03

ROE (TTM)

CAMP-19474.0%

PYXS-10177.0%

ROA (TTM)

CAMP-10642.0%

PYXS-6981.0%

ROIC (TTM)

CAMP-19457.0%

PYXS-10171.0%

Cash

CAMP$86M

PYXS$19M

Debt

CAMP$0

PYXS$0

Net Cash/Debt

CAMP$86M

PYXS$19M

Current Ratio (TTM)

CAMP4.70x

PYXS1.34x

Quick Ratio (TTM)

CAMP4.69x

PYXS1.25x

Debt/Equity (TTM)

CAMP0.00x

PYXS0.00x

Debt/Assets (TTM)

CAMP0.0%

PYXS0.0%

Interest Coverage (TTM)

CAMPN/A

PYXSN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

PYXS0.00x

Beta

CAMP-24.51

PYXS1.37

52W Performance

CAMP6.5%

PYXS-30.2%

YTD Performance

CAMP-37.2%

PYXS76.5%

% from 52W High

CAMP-51.4%

PYXS-63.4%

% from 52W Low

CAMP31.8%

PYXS97.1%

Asset Turnover (TTM)

CAMP0.79x

PYXS0.00x

FCF Yield (TTM)

CAMP-14.7%

PYXS-40.3%

Earnings Yield (TTM)

CAMP-54.8%

PYXS-38.9%

Dividend Yield (TTM)

CAMPN/A

PYXSN/A

Rule of 40

CAMP-640.9

PYXS-629.5

EV/GP/RG

CAMP0.53

PYXS0.00

Ticker research

View CAMP research View PYXS research

Metric	CAMP CAMP4 Therapeutics Corp	PYXS Pyxis Oncology Inc
Market & Valuation
Market Cap	$196M	$168M
Enterprise Value	$109M	$150M
Price	$3.77	$2.03
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	15.26x
EV/Sales	25.94x	13.55x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	15.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-2.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$11M
Revenue Growth (YoY)	40.3%	-14.2%
Forward Rev Growth	-10.8%	14187.3%
Profitability
Gross Margin (TTM)	35.8%	78.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-580.0%
Net Margin (TTM)	-2543.7%	-593.0%
FCF Margin (TTM)	-681.2%	-615.3%
Net Income (TTM)	$-107M	$-65M
FCF (TTM)	$-29M	$-68M
EPS (TTM)	-$1.85	-$1.03
ROE (TTM)	-19474.0%	-10177.0%
ROA (TTM)	-10642.0%	-6981.0%
ROIC (TTM)	-19457.0%	-10171.0%
Financial Health
Cash	$86M	$19M
Debt	$0	$0
Net Cash/Debt	$86M	$19M
Current Ratio (TTM)	4.70x	1.34x
Quick Ratio (TTM)	4.69x	1.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.37
52W Performance	6.5%	-30.2%
YTD Performance	-37.2%	76.5%
% from 52W High	-51.4%	-63.4%
% from 52W Low	31.8%	97.1%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-40.3%
Earnings Yield (TTM)	-54.8%	-38.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-629.5
EV/GP/RG	0.53	0.00
Ticker research	View CAMP research	View PYXS research